Samir Gupta, MD
Infectious Disease · Indianapolis, INNPI 1932164019
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $46,579 of the $53,383 with a category attached, or 87.3%. Viiv Healthcare Company accounts for 68.0% of it on its own, with 8 other manufacturers making up the rest. Among infectious disease clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $751.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$36K
- Gilead$17K
- Lundbeck LLC$78
- Merck$40
- Kerecis Limited$35
- Cardiva Medical, Inc.$21
- plus $49 from 3 others
Across 206 payments — averaging $6871.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$901K
- Viiv Healthcare Company$486K
- Merck$27K
- GSK$1K
What the payments were for
- Consulting fees$46,57987%
- Travel & lodging$5,0419%
- Food & beverage$1,7633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 33 | $36,319 |
| Gilead | 28 | $16,841 |
| Lundbeck LLC | 4 | $78 |
| Merck | 1 | $40 |
| Kerecis Limited | 1 | $35 |
| Cardiva Medical, Inc. | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| TELA Bio, Inc. | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$53,383 in reported general payments places this provider in the 95th percentile of 152 infectious disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Indianapolis
- Darron BrownIndianapolis$21K
- Renita BrownIndianapolis$12K
- Stephen JordanIndianapolis$3K
- Bree WeaverIndianapolis$2K
- Steven NorrisIndianapolis$2K
- Kathryn RobertsonIndianapolis$1K
- Christina TangIndianapolis$1K
- Carmen TichindeleanIndianapolis$1K
- Keith BanksIndianapolis$861
- Virginia CaineIndianapolis$643
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.